NEFL and type 2 diabetes mellitus: Researchers recommend investigating adipocytokines, neuroinflammation, and biomarkers such as GFAP and NfL in metabolism-related disorders like T2D and obesity to clarify their roles independent of amyloid and tau pathology [24].